person

Sakari K.

Country
Finland
Department
Cancer Center, Department of Oncology and Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 81 partner sites.

Specializations

Hematologic Malignancies

Investigator leads studies on Acute Lymphoblastic Leukemia. The work also covers Acute Myeloid Leukemia across pediatric and adult populations, emphasizing risk‑adapted therapy and minimal residual disease assessment.

  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Relapsed/Refractory Diffuse Large B‑Cell Lymphoma
  • High‑Risk Pediatric Medulloblastoma
  • Chronic Inflammatory Demyelinating Polyneuropathy

Efforts focus on integrating novel molecular markers with intensified chemotherapy protocols.

Solid Tumor Oncology

Work includes targeted and endocrine strategies for Breast Cancer. Additional focus is placed on Prostate Cancer and gynecologic malignancies such as Endometrial Cancer and Ovarian Cancer.

  • Breast Cancer
  • Prostate Cancer
  • Endometrial Cancer
  • Ovarian Cancer
  • Small Cell Lung Cancer

Research advances combination regimens, hormone‑blocking agents, and antibody‑drug conjugates.

Cellular and Gene‑Based Immunotherapy

Investigator evaluates safety and durability of Gene‑Modified T Cells. Studies also assess CAR‑T Cell Therapy platforms, particularly in hematologic diseases.

  • CAR‑T Cell Therapy
  • Gene‑Modified T Cells
  • Immunotherapy in Acute Lymphoblastic Leukemia
  • Targeted Molecular Inhibitors
  • Long‑Term Persistence Monitoring

Key goals include mitigating delayed adverse events and enhancing anti‑tumor efficacy.

Cardiometabolic and Vascular Health

Studies address lipid‑lowering and cardiovascular outcomes with agents such as Evolocumab. Additional investigations involve Roxadustat and metabolic disease management.

  • Evolocumab
  • Baricitinib in Type 1 Diabetes
  • Roxadustat
  • Metabolic Syndrome
  • Chronic Weight Management

Research integrates cardiovascular risk reduction with glycemic and lipid control.

Rare and Pulmonary Disorders

Investigator explores therapies for Idiopathic Pulmonary Fibrosis. Work also includes treatment of Chronic Inflammatory Demyelinating Polyneuropathy and neonatal respiratory strategies.

  • Idiopathic Pulmonary Fibrosis
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Premedication for Less Invasive Surfactant Administration
  • Respiratory Distress Syndrome
  • Rhabdomyosarcoma

Focus is on improving functional capacity and slowing disease progression.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.